These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11292359

  • 1. Nitric oxide inhibition of renal vasoconstrictor responses to sympathetic cotransmitters in the pig in vivo.
    Malmström RE, Björne H, Alving K, Weitzberg E, Lundberg JO.
    Nitric Oxide; 2001 Apr; 5(2):98-104. PubMed ID: 11292359
    [Abstract] [Full Text] [Related]

  • 2. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J, Lundberg JM.
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [Abstract] [Full Text] [Related]

  • 3. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
    DiBona GF, Sawin LL.
    J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity.
    Zhang K, Mayhan WG, Patel KP.
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R864-72. PubMed ID: 9321861
    [Abstract] [Full Text] [Related]

  • 5. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE, Lundberg JM.
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [Abstract] [Full Text] [Related]

  • 6. Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo.
    Malmström RE, Balmér KC, Weilitz J, Nordlander M, Sjölander M.
    Eur J Pharmacol; 2001 Apr 20; 418(1-2):95-104. PubMed ID: 11334870
    [Abstract] [Full Text] [Related]

  • 7. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE, Lundberg JN, Weitzberg E.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb 20; 365(2):106-11. PubMed ID: 11819028
    [Abstract] [Full Text] [Related]

  • 8. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
    Modin A, Pernow J, Lundberg JM.
    Acta Physiol Scand; 1993 May 20; 148(1):1-11. PubMed ID: 8333291
    [Abstract] [Full Text] [Related]

  • 9. SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo.
    Malmström RE, Modin A, Lundberg JM.
    Eur J Pharmacol; 1996 Jun 03; 305(1-3):145-54. PubMed ID: 8813545
    [Abstract] [Full Text] [Related]

  • 10. Pressor and renal vasoconstrictor responses to acute systemic nitric oxide synthesis inhibition are independent of the sympathetic nervous system and angiotensin II.
    Baylis C, Harvey J, Santmyire BR, Engels K.
    J Pharmacol Exp Ther; 1999 Feb 03; 288(2):693-8. PubMed ID: 9918577
    [Abstract] [Full Text] [Related]

  • 11. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS, Stjärne P, Anggärd A, Lundberg JM.
    Acta Physiol Scand; 1989 Jan 03; 135(1):17-28. PubMed ID: 2911948
    [Abstract] [Full Text] [Related]

  • 12. Differential role of nitric oxide in regional sympathetic responses to stimulation of NTS A2a adenosine receptors.
    Scislo TJ, Tan N, O'Leary DS.
    Am J Physiol Heart Circ Physiol; 2005 Feb 03; 288(2):H638-49. PubMed ID: 15539419
    [Abstract] [Full Text] [Related]

  • 13. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
    Malmström RE, Balmér KC, Lundberg JM.
    Br J Pharmacol; 1997 Jun 03; 121(3):595-603. PubMed ID: 9179405
    [Abstract] [Full Text] [Related]

  • 14. Neuropeptide Y and ATP interact to control renovascular resistance in the rat.
    Oberhauser V, Vonend O, Rump LC.
    J Am Soc Nephrol; 1999 Jun 03; 10(6):1179-85. PubMed ID: 10361855
    [Abstract] [Full Text] [Related]

  • 15. Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation?
    Mitchell JL, Morgan DA, Correia ML, Mark AL, Sivitz WI, Haynes WG.
    Hypertension; 2001 Nov 03; 38(5):1081-6. PubMed ID: 11711501
    [Abstract] [Full Text] [Related]

  • 16. Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.
    Malmström RE.
    Br J Pharmacol; 2001 Aug 03; 133(7):1073-80. PubMed ID: 11487518
    [Abstract] [Full Text] [Related]

  • 17. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A.
    Acta Physiol Scand Suppl; 1994 Aug 03; 622():1-74. PubMed ID: 7524267
    [Abstract] [Full Text] [Related]

  • 18. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
    Pernow J, Modin A, Lundberg JM.
    Eur J Pharmacol; 1992 Nov 03; 222(1):171-4. PubMed ID: 1468494
    [Abstract] [Full Text] [Related]

  • 19. Neuropeptide Y Y1 receptor mediated mesenteric vasoconstriction in the pig in vivo.
    Malmström RE.
    Regul Pept; 2000 Nov 24; 95(1-3):59-63. PubMed ID: 11062333
    [Abstract] [Full Text] [Related]

  • 20. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats.
    Vonend O, Okonek A, Stegbauer J, Habbel S, Quack I, Rump LC.
    Cardiovasc Res; 2005 May 01; 66(2):345-52. PubMed ID: 15820203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.